The epigenetic landscape of T cell exhaustion. by Sen, Debattama R et al.
Sen, Debattama R; Kaminski, James; Barnitz, R Anthony; Kurachi,
Makoto; Gerdemann, Ulrike; Yates, Kathleen B; Tsao, Hsiao-Wei;
Godec, Jernej; LaFleur, Martin W; Brown, Flavian D; Tonnerre,
Pierre; Chung, Raymond T; Tully, Damien C; Allen, Todd M; Frahm,
Nicole; Lauer, Georg M; Wherry, E John; Yosef, Nir; Haining, W
Nicholas (2016) The epigenetic landscape of T cell exhaustion. SCI-
ENCE, 354 (6316). pp. 1165-1169. ISSN 0036-8075 DOI: https://doi.org/10.1126/science.aae0491
Downloaded from: http://researchonline.lshtm.ac.uk/4652487/
DOI: 10.1126/science.aae0491
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
The epigenetic landscape of T cell exhaustion
Debattama R. Sen1,2,*, James Kaminski3,*, R. Anthony Barnitz1, Makoto Kurachi4,5, Ulrike 
Gerdemann1, Kathleen B. Yates1, Hsiao-Wei Tsao1, Jernej Godec1,2, Martin W. LaFleur1,2, 
Flavian D. Brown1,2, Pierre Tonnerre6, Raymond T. Chung6, Damien C. Tully7, Todd M. 
Allen7, Nicole Frahm8, Georg M. Lauer6, E. John Wherry4,5, Nir Yosef3,7,9,†,‡, and W. 
Nicholas Haining1,10,11,†,‡
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
2Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA
3Center for Computational Biology, University of California, Berkeley, Berkeley, CA 94720, USA
4Institute of Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA
5Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA
6Gastrointestinal Unit and Liver Center, Massachusetts General Hospital, Harvard Medical 
School, Boston, MA 02115, USA
7Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and 
Harvard University, Boston, MA 02139, USA
8Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 
98109, USA
9Department of Electrical Engineering and Computer Science, University of California, Berkeley, 
Berkeley, CA 94720, USA
10Division of Pediatric Hematology and Oncology, Children’s Hospital, Boston, MA 02115, USA
11Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142, 
USA
Abstract
Exhausted T cells in cancer and chronic viral infection express distinctive patterns of genes, 
including sustained expression of programmed cell death protein 1 (PD-1). However, the 
regulation of gene expression in exhausted T cells is poorly understood. Here, we define the 
accessible chromatin landscape in exhausted CD8+ T cells and show that it is distinct from 
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functional memory CD8+ T cells. Exhausted CD8+ T cells in humans and a mouse model of 
chronic viral infection acquire a state-specific epigenetic landscape organized into functional 
modules of enhancers. Genome editing shows that PD-1 expression is regulated in part by an 
exhaustion-specific enhancer that contains essential RAR, T-bet, and Sox3 motifs. Functional 
enhancer maps may offer targets for genome editing that alter gene expression preferentially in 
exhausted CD8+ T cells.
T cell exhaustion—an acquired state of T cell dysfunction—is a hallmark of cancer and 
chronic viral infection (1, 2), and clinical trials of checkpoint blockade, which aim to reverse 
T cell exhaustion in cancer, have proven strikingly effective (3, 4). Chimeric antigen receptor 
(CAR)–T cell therapy has also proven highly effective for hematologic malignancies (5), but 
the development of exhaustion in T cells engineered to treat solid tumors remains a 
substantial barrier to its broader use (6). The identification of mechanisms that regulate 
exhausted T cells is therefore a major goal in cancer immunotherapy.
To identify regulatory regions in the genome of exhausted CD8+ T cells, we used an assay 
for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) (7) to 
demarcate areas of accessible chromatin in mouse antigen-specific CD8+ T cells 
differentiating in response to lymphocytic choriomeningitis virus (LCMV) infection (fig. 
S1A and table S1). Acute LCMV infection elicits highly functional effector CD8+ T cells, 
whereas chronic LCMV infection gives rise to exhausted CD8+ T cells (1–3, 8, 9). Analysis 
of high-quality ATAC-seq profiles (fig. S1, B to H) from naïve CD8+ T cells and those at 
day 8 and day 27 postinfection (p.i.) (d8 and d27, respectively) revealed that naïve CD8+ T 
cells underwent large-scale remodeling (Fig. 1A and fig. S2A) during differentiation [as 
detected by DESeq2, with a false discovery rate (FDR) < 0.05]. The majority (71%) (fig. 
S2A) of chromatin-accessible regions (ChARs) either emerged (e.g., those at the Ifng locus) 
or disappeared (e.g., Ccr7) (Fig. 1A) as naïve CD8+ T cells underwent differentiation. The 
gain and loss of ChARs were not balanced; a much larger fraction of regions emerged at d8 
p.i. and persisted or emerged only at d27 than were either transiently detected at d8 p.i. or 
lost from naïve cells (Fig. 1B). Thus, differentiation from a naïve CD8+ T cell state is 
associated with a net increase, rather than decrease, in chromatin accessibility (fig. S2B).
Comparison of ChARs from exhausted CD8+ T cells with those found in functional effector 
or memory CD8+ T cells revealed marked differences in the pattern of regulatory regions. 
Differential regulatory regions between acute and chronic infection (Fig. 1C and fig. S2C) 
showed features of enhancers: They tended to be depleted of transcription start sites (TSSs) 
and enriched for intergenic and intronic areas (Fig. 1D), and found distal to gene promoters 
(fig. S2D). The magnitude of difference in the profile of regulatory regions between 
exhausted and functional CD8+ T cells was greater than that seen in gene expression. We 
found that 44.48% of all ChARs were differentially present between functional and 
exhausted cells at each time point, compared with only 9.75% of differentially expressed 
genes (both values estimated at FDR < 0.05). Consistent with this, the rank correlation 
between each T cell state by gene expression was much higher than at the level of regulatory 
regions (Fig. 1E). Thus, state change during CD8+ T cell differentiation is accompanied by a 
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larger reorganization of accessible chromatin than is apparent by examination of gene 
expression.
Unsupervised clustering identified “modules” of differential ChARs with similar patterns of 
activity across T cell states (Fig. 2A and fig. S3A). We found a highly significant positive 
correlation between the average peak intensity of ChARs within each module and the 
average gene expression of the adjacent genes (F test, P < 0.001) (Fig. 2B and fig. S3B). 
This suggests that, on average, the ChARs contained in each module tended to be associated 
with the activation, rather than repression, of corresponding genes.
Genes adjacent to ChARs in each state-specific module included many with known 
functions in the corresponding T cell state. For example, module d, active in mouse T cells 
experiencing chronic LCMV infection on d8 and d27 p.i., contained ChARs adjacent to the 
inhibitory receptors Pdcd1 and Havcr2 (which encodes Tim3) and the transcription factor 
Batf, all genes that are up-regulated in exhausted CD8+ T cells (Fig. 2B) (1, 8). Moreover, 
the functional classes of genes in each module were distinct on the basis of pathway 
enrichment (Fig. 2C and table S2). Thus, ChARs that distinguish naïve, effector, memory, 
and exhausted CD8+ T cells are organized into state-specific modules that positively regulate 
functionally distinct programs of genes.
We next sought to test whether regulatory regions specific to exhausted cells could regulate 
genes differentially expressed in exhausted CD8+ T cells. Persistent expression of PD-1 is a 
cardinal feature of exhausted CD8+ T cells, but PD-1 is also transiently expressed by 
effector CD8+ T cells during acute LCMV infection (3, 8). We identified nine ChARs within 
45 kb of the Pdcd1 gene locus (Fig. 3A) and found several that correspond to previously 
described regions with enhancer activity (−1.5 kb and −3.7 kb) (Fig. 3A) (10); these were 
present in both acute and chronic infection. We also identified an additional region (−23.8 
kb) that only showed appreciable chromatin accessibility in exhausted CD8+ T cells at d8 
and d27 p.i. from chronic infection (Fig. 3A).
We hypothesized that this ChAR might function as an enhancer of PD-1 that is required for 
persistent, high levels of expression in exhausted CD8+ T cells. Analysis of chromatin 
accessibility at this region in previously published deoxyribonuclease I–hypersensitive site–
mapping (11) or ATAC-seq data (12) showed that it was not active in other types of 
hematopoietic cells, except the murine T cell line EL4 and regulatory CD4+ T cells, both of 
which can constitutively express high levels of PD-1 (10, 13) (Fig. 3A and fig. S4A). We 
cloned a 781–base pair (bp) fragment corresponding to this region into a reporter construct 
and found that it induced a 10- to 12-fold increase in reporter gene expression, confirming 
that it could function as an enhancer (fig. S4B).
We then tested whether the −23.8 kb enhancer was necessary for high-level PD-1 
expression. We used the CRISPR-Cas9 nuclease to delete a 1.2-kb fragment at that position 
in EL4 cells, which have both sustained high-level PD-1 expression and open chromatin at 
that enhancer site (14, 15) (fig. S4, C to G). In Cas9-expressing EL4 cells transduced with a 
pair of single-guide RNAs (sgRNAs) flanking the enhancer, cells with the lowest PD-1 
expression had the highest amount of the enhancer deletion (Fig. 3B). We confirmed this 
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finding in single-cell clones and found that the expression of PD-1 in clones with a biallelic 
deletion of the target ChAR was significantly lower (P > 0.0002, Mann-Whitney U test) than 
expression in nondeleted clones (fig. S4, H to J). Deletion of this region resulted in 
decreased but not abrogated PD-1, suggesting that additional regulatory regions in EL4 cells 
are also involved in regulating PD-1 expression (Fig. 3C). Among all genes within 1.5 Mb of 
the Pdcd1 locus, only PD-1 mRNA expression was significantly decreased by deletion of the 
−23.8 kb ChAR (fig. S3K). This suggests that the −23.8 kb ChAR present in exhausted, but 
not functional, CD8+ T cells serves as an enhancer that is required to maintain high levels of 
PD-1 expression.
We next sought to identify the functional contribution of specific sequences within enhancer 
regions to the regulation of PD-1 expression. We used Cas9-mediated in situ saturation 
mutagenesis and designed all possible sgRNAs within the −23.8 kb enhancer and eight other 
regulatory sequences near the Pdcd1 locus (15, 16) (Fig. 3A). We transduced Cas9-
expressing EL4 cells with a pool of 1754 enhancer-targeting sgRNAs, 117 sgRNAs targeting 
the Pdcd1 exons as positive controls, and 200 nontargeting sgRNAs as negative controls (fig. 
S5, A and B). We sorted transduced EL4s into populations on the basis of high or low PD-1 
expression and quantified the abundance of individual sgRNAs (fig. S5C).
In comparison with nontargeting sgRNAs, which were equivalently distributed between 
PD-1–high and PD-1–low fractions, sgRNAs targeting Pdcd1 exons were highly enriched in 
the PD-1–low fraction as expected (Fig. 3D and fig. S5, D and E). sgRNAs targeting eight of 
the nine regulatory regions were also significantly enriched in the PD-1–low fraction to 
varying degrees (P < 0.00001 to P < 0.01, see supplementary methods), suggesting that 
critical sequences affecting PD-1 expression are densely represented within each of the eight 
regulatory regions. However, sgRNAs in the −35.6 kb ChAR had no significant effect on 
PD-1 expression, consistent with prior observations that this region falls outside the 
CCCTC-binding factor (CTCF)–mediated boundaries of the Pdcd1 locus (10).
We focused on sgRNAs inducing cleavage in the −23.8 kb enhancer (fig. S5F) and found a 
strong correlation between the predicted activity in a pooled setting (PD-1 high:low ratio >1 
SD below mean) and their effect on PD-1 mean fluorescence intensity in individual cell lines 
(P = 0.0041) (fig. S5, G and H). Inspection of the predicted cleavage-site locations revealed 
three critical regions of the enhancer in which cleavage markedly affected PD-1 expression 
(Fig. 3E, gray shading).
We next asked whether these critical regions in the −23.8 kb enhancer were associated with 
distinct patterns of transcription factor (TF) binding in exhausted CD8+ T cells in vivo. We 
identified TF footprints (17) using ATAC-seq cut sites from CD8+ T cells experiencing 
chronic infection, which allowed us to infer TF binding within the −23.8 kb enhancer (Fig. 
3E; fig. S6, A to D; fig. S7A; and tables S3 to S6). We found that cleavage sites of sgRNAs 
that reduced PD-1 expression in EL4 cells were significantly enriched in TF footprints found 
in exhausted CD8+ cells in vivo (P = 8.63 × 104, hypergeometric test). The three TF 
footprints with greatest sensitivity to disruption corresponded to motifs for Sox3, T-bet 
(encoded by Tbx21), and retinoic acid receptor (RAR) in exhausted CD8+ T cells in vivo 
(Fig. 3F and fig. S7B). Indeed, comparison of genome-wide TF footprinting between 
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chronic and acute infection at d27 to identify TF motifs that showed significantly differential 
inferred binding (Fig. 3G, fig. S7C, and tables S3 and S5) confirmed that Rara binding was 
significantly enriched in exhausted CD8+ T cells (FDR = 3.14 × 10−13) compared with their 
functional counterparts.
To test whether T cell exhaustion is also associated with a distinct epigenetic state in human 
exhausted CD8+ T cells, we analyzed global patterns of chromatin accessibility in tetramer+ 
CD8+ T cells from four subjects with chronic progressive HIV-1 who were not on therapy 
(Fig. 4, A and B; fig. S8, A and B; and table S7). We successfully mapped 80 to 85% of 
ChARs identified in the mouse model to their human orthologous regions (Fig. 4A, colored 
blocks, and fig. S8C) (18, 19) and found them to be enriched for disease-associated single-
nucleotide polymorphisms (SNPs) (probabilistic identification of causal SNPs, P < 2.77 × 
10−8; hyper-geometric test) (fig. S8D) (20) and, in particular, immune-related National 
Human Genome Research Institute genome-wide association study SNPs (P < 3.70 × 10−3) 
(fig. S8, E to G). This enrichment strongly suggested that mapped regions corresponded to 
functional regulatory regions within the immune system. Regions at the Pdcd1 locus were 
not among those mapped from the mouse model, as previously observed (10), which limited 
our ability to detect an ortholog to the −23.8 kb enhancer observed in the mouse model.
Human naïve CD8+ T cells from the majority of donors showed greater chromatin 
accessibility in naïve-specific regions defined in the mouse than in memory- or exhaustion-
specific regions. In the healthy donor, CMV-specific tetramer+ CD8+ T cells, and effector 
memory cells were enriched for memory-specific regions (Mann-Whitney U test, P = 0.01 to 
P < 0.0001) (Fig. 4C and fig. S8H). In contrast, HIV-specific tetramer+ cells from three out 
of the four subjects showed significantly greater chromatin accessibility in exhaustion-
specific regions (Mann-Whitney U test, P = 0.05 to P < 0.001) than in memory-specific 
regions.
Finally, we confirmed these findings in a subject with chronic hepatitis C virus (HCV) 
infection in whom CD8+ T cell responses to two epitopes of HCV could be detected (Fig. 
4D). Sequencing of the HCV genome in this subject revealed that, unlike the C63B epitope, 
the 174D epitope had undergone extensive viral escape, and no wild-type viral sequence 
could be detected (Fig. 4E). We found that the C63B tetramer+ cells had a phenotype 
consistent with exhaustion and showed significantly greater chromatin accessibility at 
exhaustion-specific regions (Mann-Whitney U test, P = 0.01) than memory regions (Fig. 
4F). In contrast, 174D tetramer+ cells, which were specific for the escape mutant epitope, 
lacked exhaustion-specific surface markers and showed greater chromatin accessibility in 
memory-specific regions, as did influenza-specific CD8+ T cells (Mann-Whitney U test, P = 
0.04) (Fig. 4F). Thus, the state-specific pattern of chromatin accessibility found in mouse 
exhausted CD8+ T cells is conserved in human exhausted CD8+ T cells.
We find that CD8+ T cell exhaustion occurs with a broad remodeling of the enhancer 
landscape and TF binding. This suggests that exhausted CD8+ T cells occupy a 
differentiation state distinct from functional memory CD8+ T cells. Identifying the plasticity 
of this state and whether or how it could be reverted becomes a critical question for 
immunotherapy applications. Our data also suggest that mapping state-specific enhancers in 
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exhausted T cells could enable more precise genome editing for adoptive T cell therapy. 
Genome editing of CAR-T cells to make them resistant to exhaustion is an appealing 
concept and has led to recent studies investigating the deletion of the PD-1 gene locus (21, 
22). Editing exhaustion-specific enhancers (15) may provide a more “tunable” and state-
specific approach to modulate T cell function than deleting coding regions of genes. 
Functional maps of enhancers specific to exhausted CD8+ T cells may therefore provide a 
crucial step toward the rational engineering of T cells for therapeutic use.
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Fig. 1. CD8+ Tcell exhaustion is associated with extensive changes in accessible chromatin
(A) Representative ATAC-seq tracks at the Ccr7 and Ifng gene loci. (B) Developmental 
trajectory of new regions at each time point. (C) Overlap in ChARs between cell states. (D) 
Distribution of nondifferential (left) and differential (right) regions between acute and 
chronic CD8+ T cell states. TSS, transcription start site. (E) Correlation network of 
similarity between states measured by gene expression (left) and chromatin accessibility 
(right). Edge length corresponds to similarity (Spearman correlation).
Sen et al. Page 7
Science. Author manuscript; available in PMC 2017 December 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2. State-specific enhancers in CD8+ T cells form modules that map to functionally distinct 
classes of genes
(A) Heat map of peak intensity for all differentially accessible regions (rows) clustered by 
similarity across cell states (columns). Shown are normalized numbers of cut sites 
(supplementary methods), scaled linearly from row minimum (white) to maximum (purple). 
(B) Heat map showing row-normalized average mRNA expression of neighboring genes 
within each module in (A) in each cell state. Informative genes from each module are shown 
on right. (C) Heat map showing enrichment of Gene Ontology (GO) terms (rows) in each 
module (columns). P-values (hypergeometric test) presented as −log10.
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Fig. 3. High-resolution functional mapping of an exhaustion-specific enhancer identifies minimal 
sequences that regulate PD-1
(A) ATAC-seq tracks from CD8+ T cells, EL4 cell line, and regulatory CD4+ T cells (12). 
Arrowheads indicate individual ChARs. (B) Cell sorting gates (top) and corresponding 
genomic polymerase chain reaction amplification for the PD-1 enhancer region (bottom) 
showing proportion of wild-type (WT) or deleted (Del) alleles in EL4 cells transfected with 
control (left) or double-cut sgRNAs (right). Representative data shown from two replicates. 
(C) PD-1 expression of EL4 WT (light gray) or representative enhancer-deleted (red) single-
cell clone out of 46 clones. (D) Normalized enrichment of sgRNAs (gray symbols) within 
PD-1–high and PD-1–low populations at locations shown (supplementary methods). Control 
nontargeting sgRNAs are pseudo mapped with 5-bp spacing. Red symbols correspond to the 
21 sgRNAs with the largest effect within the −23.8 kb enhancer, for which isogenic cell lines 
were later produced. (E) Overlap of TF footprints and sgRNA activity within the −23.8 kb 
enhancer. TF footprints with binding probability >0.9 in chronic d27 are shown on top. 
Lines represent cut sites of top-scoring sgRNAs. Change in PD-1 mean fluorescence 
intensity (MFI) relative to control guide transfected populations for each sgRNA (red 
symbol, left axis); 10-bp running average of PD-1 MFI changes caused by sgRNA activity 
shown in black (right axis). (F) sgRNA cut sites within the SOX3, TBX21, and RAR motifs. 
(G) Log fold enrichment of predicted TF footprints in acute d27 versus chronic d27 CD8+ T 
cells (x axis) (see supplementary methods) are plotted against the corresponding P-value 
(hypergeometric).
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Fig. 4. Exhaustion-specific epigenetic profiles in the mouse are conserved in antigen-specific 
exhausted human T cells in HIV-1 infection
(A) Representative ATAC-seq tracks from naïve, HIV-1 tetramer+, and CMV tetramer+ 
samples at the IFNG gene locus (top). Orthologous regions from five mouse cell states at the 
IFNG locus, based on mapping of mouse ChARs to the human genome (colored blocks, 
bottom). (B) Schematic diagram of mouse and human comparative analysis. (C) Heat map 
of average chromatin accessibility at regions orthologous to mouse naïve, memory, and 
exhaustion enhancers in human samples indicated. Color scale as in Fig. 2A. (D) PD-1 and 
CD39 expression measured by flow cytometry in HCV C63B tetramer+, HCV 174D 
tetramer+, and influenza (flu) matrix peptide (MP) tetramer+ populations from a single 
HCV-infected donor. (E) Viral sequences encoding C63B and 174D epitopes. (F) Heat map 
of average chromatin accessibility at regions orthologous to mouse naïve, memory, and 
exhaustion enhancers in human samples indicated from a single HCV-infected donor.
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